A petition is public. Its outcome isn't.

A competitor can ask FDA to move your product code from Class II to Class III, or argue your device type never belonged in the class it’s in, without opening a 510(k), without citing a recall, and without you hearing about it from any source keyed to the Federal Register. The vehicle is a reclassification petition under 21 CFR 860.130, and the regulation is explicit about who can file one: “an interested person.” That is a low bar, and the petition is public from the moment FDA receives it — just not anywhere a classification-change watch is looking.

What the petition has to contain

21 CFR 860.123 sets the content: the device type by name, the action requested — a specific move, Class III to Class II or the reverse — the petitioner’s basis for disagreeing with the present classification, and, where the petition rests on new information, a summary of it including representative data that runs against the petitioner’s own position. It is a real filing with real content requirements, built to be evaluated, not a form letter.

The 180 days, and what they end in

Under 860.130, FDA has 180 days from filing to do one of two things: deny the petition, or give notice of intent to initiate a change in the device’s classification. Both outcomes are real decisions on a real clock. Neither one requires a Federal Register document to exist before the 180 days are up — the clock runs on the petition’s own filing date, and the public record most monitoring is built to read starts later, if it starts at all.

The petition is on file the day it lands. The notice that would put it in front of a Federal-Register-keyed watch is a separate, later, optional event.

Where it sits while it waits

A reclassification petition’s contents are available for public disclosure at the time FDA receives it — it is not sealed pending a decision. It is also not a Federal Register filing, so it does not appear in the source dense enough to carry classification changes and final rules, the one FDA Radar’s own ingestion reads for exactly that category. A petition sitting inside its 180-day window, filed against a product code that matters to a specific portfolio, is invisible to that source for as long as it sits there — which, procedurally, can be the full 180 days.

What this doesn’t change

None of this says a specific petition exists against a specific product code, or what its odds are if one does. Checking is a direct question to FDA’s Dockets Management, not an inference from silence in a Federal Register feed. Per FDA Radar’s editorial standards, this is regulatory intelligence about a gap between when a filing exists and when it becomes visible to Federal-Register-keyed monitoring — never regulatory advice about filing, contesting, or ignoring one.